Get the Stockscreener App
5.56
1.65%
0.09
Achieve Life Sciences Inc stock is traded at $5.56, with a volume of 853.70K.
It is up +1.65% in the last 24 hours and up +18.80% over the past month.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.
See More
Previous Close:
$5.47
Open:
$5.51
24h Volume:
853.70K
Relative Volume:
0.77
Market Cap:
$295.98M
Revenue:
-
Net Income/Loss:
$-32.94M
P/E Ratio:
-5.009
EPS:
-1.11
Net Cash Flow:
$-24.95M
1W Performance:
+11.87%
1M Performance:
+18.80%
6M Performance:
+134.60%
1Y Performance:
+57.95%
1-Day Range:
$5.37
$5.62
1-Week Range:
$4.90
$5.62
52-Week Range:
$1.84
$5.78
Achieve Life Sciences Inc Stock (ACHV) Company Profile
Name
Achieve Life Sciences Inc
Sector
Industry
Phone
425-686-1500
Address
22722 29TH DR. SE, SEATTLE, BC
Compare ACHV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ACHV
Achieve Life Sciences Inc
|
5.56 | 291.19M | 0 | -32.94M | -24.95M | -1.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.86 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
796.55 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
398.29 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
788.49 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.97 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Achieve Life Sciences Inc Stock (ACHV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-25-25 | Initiated | Citizens JMP | Mkt Outperform |
| Aug-21-25 | Initiated | H.C. Wainwright | Buy |
| Nov-14-24 | Initiated | Rodman & Renshaw | Buy |
| Sep-27-24 | Initiated | Raymond James | Strong Buy |
| May-10-23 | Reiterated | Maxim Group | Buy |
| Jun-23-21 | Initiated | Oppenheimer | Outperform |
View All
Achieve Life Sciences Inc Stock (ACHV) Latest News
Can Achieve Life Sciences Inc. stock continue upward trendPortfolio Gains Report & AI Enhanced Trading Alerts - ulpravda.ru
Why Achieve Life Sciences Inc. stock is recommended by analystsJuly 2025 Market Mood & Weekly Top Stock Performers List - ulpravda.ru
Will Achieve Life Sciences Inc. stock benefit from automation2025 Bull vs Bear & Proven Capital Preservation Methods - ulpravda.ru
Can Achieve Life Sciences Inc. stock resist sector downturns2025 Trading Volume Trends & Long-Term Capital Growth Strategies - ulpravda.ru
Is Achieve Life Sciences Inc. stock undervalued vs historical averages2025 Bull vs Bear & Expert Curated Trade Setups - ulpravda.ru
How supply chain issues affect Achieve Life Sciences Inc. stockGlobal Markets & Momentum Based Trading Ideas - ulpravda.ru
Will Achieve Life Sciences Inc. stock outperform value stocks2025 Geopolitical Influence & High Win Rate Trade Tips - ulpravda.ru
Will Achieve Life Sciences Inc. stock deliver strong dividend growth2025 Sector Review & Smart Swing Trading Alerts - ulpravda.ru
Achieve Life Sciences, Inc.Common Shares (NQ: ACHV - FinancialContent
Achieve Life Sciences gets new interim chief medical officer - MSN
11 creative campaigns to know about today - Ad Age
Will Achieve Life Sciences Inc. (SP4P) stock rise with strong economyStock Price Divergence & Free Grow Wealth With Picks - ulpravda.ru
What analysts say about Achieve Life Sciences Inc stockLow Risk Investment Ideas & Rapid Portfolio Investment - earlytimes.in
Aug Wrap: Can Achieve Life Sciences Inc. stock continue upward trendMarket Trend Review & Free Accurate Trade Setup Notifications - moha.gov.vn
Achieve Life Sciences (NASDAQ:ACHV) Share Price Crosses Above 200-Day Moving AverageHere's Why - MarketBeat
How risky is Achieve Life Sciences Inc. (SP4P) stock compared to peers2026 world cup usa national team round of 16 midfield engines transition play match prediction analysis - ulpravda.ru
Achieve Life Sciences jumps on Hunterbrook Capital endorsement - MSN
Achieve Life Sciences (ACHV) Identified as Top Biopharma Prospec - GuruFocus
Options Flow: Will Achieve Life Sciences Inc stock outperform value stocksDividend Hike & Step-by-Step Swing Trade Plans - moha.gov.vn
When Will Achieve Life Sciences, Inc. (NASDAQ:ACHV) Become Profitable? - simplywall.st
Achieve Life Sciences: Market Watchdogs Eager - StocksToTrade
Achieve Life Sciences’ Smoking Treatment Likely To Be Approved By FDA, Says Hunterbrook - Stocktwits
Achieve Life Sciences (ACHV) Gains on Promising Cytisinicline An - GuruFocus
New Report Calls Achieve Life's Cytisinicline Best Therapy To Quit Smoking - Sahm
Achieve Life Sciences (ACHV) Nears FDA Approval for Anti-Smoking Drug - GuruFocus
Achieve Life Sciences shares rise as Hunterbrook Capital takes bullish position - Investing.com Canada
Achieve Life Sciences (NASDAQ:ACHV) Shares Cross Above Two Hundred Day Moving AverageHere's Why - MarketBeat
ACHV (Achieve Life Sciences) EV-to-OCF : -4.70 (As of Dec. 21, 2025) - GuruFocus
Published on: 2025-12-21 13:53:54 - Улправда
How Achieve Life Sciences Inc. (SP4P) stock performs during market turbulenceJuly 2025 Reactions & Smart Allocation Stock Tips - Улправда
CEO Moves: Can Achieve Life Sciences Inc. stock continue upward trend2025 Valuation Update & Weekly Watchlist for Consistent Profits - ulpravda.ru
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Achieve Life Sciences (NASDAQ:ACHV) Stock Price Passes Above Two Hundred Day Moving AverageTime to Sell? - MarketBeat
Market Fear: Why Achieve Life Sciences Inc. stock is a value investor pickMarket Performance Recap & Low Drawdown Momentum Trade Ideas - moha.gov.vn
How Achieve Life Sciences Inc. stock performs in weak economyForecast Cut & AI Optimized Trading Strategy Guides - Улправда
Achieve Life Sciences (FRA:SP4P) EV-to-OCF : -4.51 (As of Dec. 19, 2025) - GuruFocus
How Achieve Life Sciences Inc. stock compares to industry benchmarksJuly 2025 Chart Watch & Accurate Entry/Exit Alerts - DonanımHaber
Bear Alert: How Achieve Life Sciences Inc. stock benefits from tech adoptionMarket Sentiment Review & Weekly Top Gainers Alerts - ulpravda.ru
How Achieve Life Sciences Inc. stock benefits from tech adoptionJuly 2025 Technicals & Free Community Supported Trade Ideas - Улправда
Is Achieve Life Sciences Inc. stock dividend yield sustainableQuarterly Profit Report & Accurate Entry and Exit Point Alerts - Улправда
Alert wrongly tagged to Achieve Life Sciences withdrawn - marketscreener.com
Achieve Life Sciences (FRA:SP4P) EV-to-OCF : -4.36 (As of Dec. 18, 2025) - GuruFocus
Achieve Life Sciences to Host Meetings During the J.P. Morgan Healthcare Conference Week - Financial Times
Support Test: Why Achieve Life Sciences Inc stock is a value investor pickJuly 2025 Macro Moves & AI Enhanced Trading Alerts - moha.gov.vn
Fed Watch: sxmbWeekly Trade Review & Accurate Buy Signal Notifications - moha.gov.vn
Gains Recap: Is Pimco High Income Fund stock nearing a technical breakoutJuly 2025 Outlook & High Return Stock Watch Alerts - moha.gov.vn
Achieve Life Sciences (NASDAQ:ACHV) Share Price Passes Above Two Hundred Day Moving AverageHere's What Happened - MarketBeat
Achieve Life Sciences Inc Stock (ACHV) Financials Data
Revenue
Net Income
Cash Flow
EPS
Achieve Life Sciences Inc Stock (ACHV) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Oki Mark K | Chief Financial Officer |
Sep 18 '25 |
Sale |
2.92 |
50,060 |
146,175 |
127,940 |
| Stewart Richard Alistair | Chief Executive Officer |
Sep 18 '25 |
Option Exercise |
0.00 |
297,500 |
0 |
358,376 |
| Stewart Richard Alistair | Chief Executive Officer |
Sep 18 '25 |
Sale |
2.92 |
129,501 |
378,143 |
228,875 |
| Wan Jerry | Principal Accounting Officer |
Sep 04 '25 |
Option Exercise |
0.00 |
34,100 |
0 |
46,764 |
| Wan Jerry | Principal Accounting Officer |
Sep 04 '25 |
Sale |
2.77 |
14,070 |
38,974 |
32,694 |
| KING THOMAS BRAXTON | Director |
Sep 04 '25 |
Option Exercise |
0.00 |
455,000 |
0 |
455,000 |
| KING THOMAS BRAXTON | Director |
Sep 04 '25 |
Sale |
2.77 |
139,858 |
387,407 |
315,142 |
| JACOBS CINDY | President & CMO |
Sep 04 '25 |
Option Exercise |
0.00 |
110,000 |
0 |
143,214 |
| JACOBS CINDY | President & CMO |
Sep 04 '25 |
Sale |
2.77 |
27,629 |
76,532 |
115,585 |
| Xinos Jaime | Chief Commercial Officer |
Sep 04 '25 |
Option Exercise |
0.00 |
69,000 |
0 |
95,286 |
0.90%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):